4.3 Review

Recent Insights into the Mitochondrial Role in Autophagy and Its Regulation by Oxidative Stress

Journal

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
Volume 2019, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2019/3809308

Keywords

-

Categories

Funding

  1. Ministerio de Ciencia, Innovacion y Universidades Agencia Estatal de Investigacion and Fondo Europeo de Desarrollo Regional (MCIU/AEI/FEDER, UE) [RTI2018-095572-B-100, RTI2018-095672-BI00, SAF2015-66515-R]
  2. Instituto de Salud Carlos III [PI16/00930, PI19/01410]
  3. Fundacio La Marato de TV3 [2014-0930]
  4. AGAUR [2017_SGR_177]
  5. CERCA Programme from the Generalitat de Catalunya
  6. MCIU

Ask authors/readers for more resources

Autophagy is a self-digestive process that degrades intracellular components, including damaged organelles, to maintain energy homeostasis and to cope with cellular stress. Autophagy plays a key role during development and adult tissue homeostasis, and growing evidence indicates that this catalytic process also has a direct role in modulating aging. Although autophagy is essentially protective, depending on the cellular context and stimuli, autophagy outcome can lead to either abnormal cell growth or cell death. The autophagic process requires a tight regulation, with cellular events following distinct stages and governed by a wide molecular machinery. Reactive oxygen species (ROS) have been involved in autophagy regulation through multiple signaling pathways, and mitochondria, the main source of endogenous ROS, have emerged as essential signal transducers that mediate autophagy. In the present review, we aim to summarize the regulatory function of mitochondria in the autophagic process, particularly regarding the mitochondrial role as the coordination node in the autophagy signaling pathway, involving mitochondrial oxidative stress, and their participation as membrane donors in the initial steps of autophagosome assembly.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease

Vicente Roca-Agujetas, Elisabet Barbero-Camps, Cristina de Dios, Petar Podlesniy, Xenia Abadin, Albert Morales, Montserrat Mari, Ramon Trullas, Anna Colell

Summary: Accumulation of intracellular cholesterol hinders the clearance of defective mitochondria, suggesting restoration of cholesterol homeostasis and mitochondrial scavenging of ROS as potential therapeutic targets for Alzheimer's disease.

MOLECULAR NEURODEGENERATION (2021)

Editorial Material Biochemistry & Molecular Biology

Mitochondrial Oxidative and Nitrosative Stress as a Therapeutic Target in Diseases

Montserrat Mari, Anna Colell

ANTIOXIDANTS (2021)

Article Medicine, General & Internal

Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis

Neus Martinez-Bosch, Helena Cristobal, Mar Iglesias, Meritxell Gironella, Luis Barranco, Laura Visa, Domenico Calafato, Silvia Jimenez-Parrado, Julie Earl, Alfredo Carrato, Noemi Manero-Ruperez, Mireia Moreno, Albert Morales, Carmen Guerra, Pilar Navarro, Pablo Garcia de Frutos

Summary: This study explores the use of sAXL as a biomarker for pancreatic ductal adenocarcinoma (PDAC). The research shows that AXL is increased in PDAC tissues and plasma sAXL concentrations are elevated in PDAC patients. Higher levels of AXL are associated with lower overall survival. sAXL performs better than CA19-9 in discriminating between PDAC and chronic pancreatitis (CP). The combination of sAXL and CA19-9 improves the diagnostic value.

EBIOMEDICINE (2022)

Review Oncology

Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances

Blanca Cucarull, Anna Tutusaus, Patricia Rider, Tania Hernaez-Alsina, Carlos Cuno, Pablo Garcia de Frutos, Anna Colell, Montserrat Mari, Albert Morales

Summary: Hepatocellular carcinoma (HCC) is the most common form of liver cancer with poor prognosis and increasing incidence. Recent advances in systemic treatment options, including tyrosine kinase inhibitors, antiangiogenic antibodies, and immune checkpoint inhibitors, have provided hope for HCC patients. Understanding the specific molecular mechanisms that influence tumor growth and immune control in HCC is crucial for physician decision-making and developing effective treatments.

CANCERS (2022)

Article Neurosciences

Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis

Cristina de Dios, Xenia Abadin, Vicente Roca-Agujetas, Marina Jimenez-Martinez, Albert Morales, Ramon Trullas, Montserrat Mari, Anna Colell

Summary: The sustained activation of inflammasomes in Alzheimer's disease (AD) is not well understood. This study examines whether cholesterol-mediated changes can regulate the inflammasome pathway. It was found that cholesterol levels affect the inflammasome-mediated immune response in microglia and neuronal cells differently, and cholesterol modulation may be a potential therapeutic target for AD treatment.

TRANSLATIONAL NEURODEGENERATION (2023)

Article Health Care Sciences & Services

Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction

Helena Cristobal, Cristina Enjuanes, Montserrat Batlle, Marta Tajes, Begona Campos, Josep Francesch, Pedro Moliner, Marta Farrero, Rut Andrea, Jose Tomas Ortiz-Perez, Albert Morales, Manel Sabate, Josep Comin-Colet, Pablo Garcia de Frutos

Summary: Heart failure (HF) is classified based on left ventricular ejection fraction (EF) into HF with reduced, mildly reduced, and preserved EF. Biomarkers may differ depending on EF type. This study analyzed the levels of soluble form of the AXL receptor tyrosine kinase (sAXL) in HF patients with reduced and preserved EF. The results showed that sAXL levels were a reliable predictor for all-cause and cardiovascular mortality only in the HFpEF cohort.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Article Endocrinology & Metabolism

Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice

Carlos Cuno-Gomiz, Estefania de Gregorio, Anna Tutusaus, Patricia Rider, Nuria Andres-Sanchez, Anna Colell, Albert Morales, Montserrat Mari

Summary: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common liver condition today. In its more advanced form, called metabolic dysfunction-associated steatohepatitis (MASH), adult men are more often affected than women, though this difference vanishes after menopause. Various factors contribute to MASH, including a specific immune cell type called NKT cells, which has not been deeply researched yet. To explore the role of NKT cells in steatohepatitis, we used male and female mice with or without NKT cells (CD1d-/- mice), feeding them a high-fat diet that induces steatohepatitis. Our findings revealed that female mice had less severe steatohepatitis compared to males. Interestingly, we observed a protective role of NKT cells during steatohepatitis, as male mice without these cells had more damage, inflammation, and fibrosis than those with NKT cells. However, in females, even though those lacking NKT cells showed more liver damage and immune alterations, NKT did not seem to play a major role in early steatohepatitis progression. Notably, females had much fewer NKT cells in their livers compared to males, possibly explaining this difference. In conclusion, NKT cells seem to slow down steatohepatitis progression, especially in male mice. In females, their impact on early steatohepatitis advance appears more limited.

BIOLOGY OF SEX DIFFERENCES (2023)

Meeting Abstract Gastroenterology & Hepatology

Mitochondrial damage, revealed as key factor in cabozantinib efficacy against hepatocellular carcinoma, is potentiated by the BH3-mimetic navitoclax

Anna Tutusaus, Blanca Cucarull, Patricia Rider, Carlos Cuno, Pablo Garcia de Frutos, Loreto Boix, Montserrat Mari, Albert Morales

JOURNAL OF HEPATOLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

The AXL inhibitor bemcentinib reduces inflammation and fibrosis by inducing a dynamic change in macrophages and CD8+T cells subsets during experimental NASH

Sturla M. Groendal, Anna Tutusaus, Pablo Garcia de Frutos, Magnus Blo, Linn Hodneland, Gro Gausdal, Akil Jackson, James B. Lorens, Albert Morales, Montserrat Mari

JOURNAL OF HEPATOLOGY (2022)

No Data Available